Striking ability of adenosine-2′(3′)-deoxy-3′(2′)-triphosphates and related analogues to replace ATP as phosphate donor for all four human, and the Drosophila Melanogaster, deoxyribonucleoside kinases

Nucleosides, Nucleotides and Nucleic Acids

Volumn 22, Issue 2, 2003, Pages 153-173

  Krawiec, Krzysztof ^a   Kierdaszuk, Borys ^a   Kalinichenko, Elena N ^b   Rubinova, Elena B ^b   Mikhailopulo, Igor A ^b   Eriksson, Staffan ^c   Munch Petersen, Birgitte ^d   Shugar, David ^a,e  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d ROSKILDE UNIVERSITY   (Denmark)

^e INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Adenosine 2 (3) deoxy 3 (2 ) triphosphates; ATP analogues; Deoxyribonucleoside kinases; Donor acceptor interdependence

Indexed keywords

3' DEOXYADENOSINE 2' TRIPHOSPHATE; ADENOSINE 2' TRIPHOSPHATE; ADENOSINE 2'(3') DEOXY 3'(2') TRIPHOSPHATE; ADENOSINE 3' TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE KINASE; DEOXYRIBONUCLEOSIDE KINASE; PHOSPHATE; PHOSPHOTRANSFERASE; THYMIDINE KINASE; THYMIDINE KINASE 1; THYMIDINE KINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; EXPERIMENTAL MODEL; HUMAN; KINETICS; MICHAELIS CONSTANT; MITOCHONDRION; NONHUMAN; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; STRUCTURE ANALYSIS;

ANIMALS; BINDING SITES; CHROMATOGRAPHY, THIN LAYER; DEOXYADENINE NUCLEOTIDES; DROSOPHILA MELANOGASTER; FURANS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; MOLECULAR CONFORMATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP;

DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0037263895     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120019510     Document Type: Article

References (58)

1. Arner, E.S.; Eriksson, S. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 1995, 67, 155-186.
2. Munch-Petersen, B.; Piškur, J.; Sondergaard, L. Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase. J. Biol. Chem. 1998, 273, 3926-3931.
3. Gentry, G.A. Viral thymidine kinases and their relatives. Pharmacol. Ther. 1992, 54, 319-355.
4. Shugar, D. Molecular Aspects of Chemotherapy; Shugar, D., Rode, W., Borowski, E., Eds.; Springer-Verlag: Berlin and New York, 1992; 239-270.
5. De Clercq, E. Strategies in the design of antiviral drugs. Nature Reviews Drug Discovery 2002, 1, 13-25.
6. Shugar, D. The NTP phosphate donor in kinase reactions: is ATP a monopolist? Acta Biochim. Pol. 1996, 43, 9-23.
7. Andersen, R.B.; Neuhard, J. Deoxynucleoside kinases encoded by the yaaG and yaaF genes of Bacillus subtilis. Substrate specificity and kinetic analysis of deoxyguanosine kinase with UTP as the preferred phosphate donor. J. Biol. Chem. 2001, 276, 5518-5524.
8. Krawiec, K.; Kierdaszuk, B.; Eriksson, S.; Munch-Petersen, B.; Shugar, D. Nucleoside triphosphate donors for nucleoside kinases: donor properties of UTP with human deoxycytidine kinase. Biochem. Biophys. Res. Commun. 1995, 216, 42-48.
9. Shewach, D.S.; Reynolds, K.K.; Hertel, L. Nucleotide specificity of human deoxycytidine kinase. Mol. Pharmacol. 1992, 42, 518-524.
10. White, J.C.; Capizzi, R.L. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-β-D-arabinofuranosylcytosine phosphorylation in human leukemia cells. Cancer Res. 1991, 51, 2559-2565.
11. Eglund, P.T.; Huberman, J.A.; Jovin, T.M.; Kornberg, A. Enzymatic synthesis of deoxyrybonucleic acid. XXX. Binding of triphosphates to deoxyribonucleic acid polymerase. J. Biol. Chem. 1969, 244, 3038-3044.
12. Sahyoun, N.; Schmitges, C.J.; Siegel, M.I.; Cuatrecasas, P. 2′-Deoxyadenosine-3′-monophosphate: a naturally occurring inhibitor of adenylate cyclase in amphibian and mammalian cells. Life Sci. 1976, 19, 1961-1970.
13. Schneider, B.; Xu, Y.W.; Janin, J.; Veron, M.; Deville-Bonne, D. 3′-Phosphorylated nucleotides are tight binding inhibitors of nucleoside diphosphate kinase activity. J. Biol. Chem. 1998, 273, 28,773-28,778.
14. Leonidas, D.D.; Shapiro, R.; Irons, L.I.; Russo, N.; Acharya, K.R. Crystal structures of ribonuclease A complexes with 5′-diphosphoadenosine 3′-phosphate and 5′-diphosphoadenosine 2′-phosphate at 1.7 Å resolution. Biochemistry 1997, 36, 5578-5588.
15. Johnson, R.A.; Desaubry, L.; Bianchi, G.; Shoshani, I.; Lyons, E. Jr.; Taussig, R.; Watson, P.A.; Cali, J.J.; Krupinski, J.; Pieroni, J.P.; Iyengar, R. Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3′-polyphosphates. J. Biol. Chem. 1997, 272, 8962-8966.
16. Krawiec, K.; Kierdaszuk, B.; Kalinichenko, E.N.; Mikhailopulo, I.A.; Shugar, D. Unusual nucleoside triphosphate donors for nucleoside kinases: 3′-deoxyadenosine-2′-triphosphate and 2′-deoxyadenosine-3′-triphosphate. Acta Biochim. Polon 1998, 45, 87-94.
17. Chottiner, E.G.; Shewach, D.S.; Datta, N.S.; Ashcraft, E.; Gribbin, D.; Ginsburg, D.; Fox, I.H.; Mitchell, B.S. Cloning and expression of human deoxycytidine kinase cDNA. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1531-1535.
18. Wang, L.; Hellman, U.; Eriksson, S. Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA. FEBS Lett. 1996, 390, 39-43.
19. Johansson, M.; Karlsson, A. Cloning and expression of human deoxyguanosine kinase cDNA. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 7258-7262.
20. Berenstein, D.; Christensen, J.F.; Kristensen, T.; Hofbauer, R.; Munch-Petersen, B. Valine, not methionine, is amino acid 106 in human cytosolic thymidine kinase (TK1). Impact on oligomerization, stability, and kinetic properties. J. Biol. Chem. 2000, 275, 32187-32192.
21. Wang, L.; Munch-Peterson, B.; Herrström Sjöberg, A.; Hellman, U.; Bergman, T.; Jornvall, H.; Eriksson, S. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett. 1999, 443, 170-174.
22. Munch-Petersen, B.; Knecht, W.; Lenz, C.; Sondergaard, L.; Piškur, J. Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants. J. Biol. Chem. 2000, 275, 6673-6679.
23. Munch-Petersen, B.; Tyrsted, G.; Cloos, L. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. J. Biol. Chem. 1993, 268, 15621-15625.
24. Munch-Petersen, B.; Tyrsted, G.; Cloos, L.; Beck, R.A.; Eger, K. Different affinity of the two forms of human cytosolic thymidine kinase towards pirimidine analogs. Biochim. Biophys. Acta 1995, 1250, 158-162.
25. Ives, D.H.; Durham, J.P.; Tucker, V.S. Rapid determination of nucleoside kinase and nucleotidase activities with tritium-labeled substrates. Anal. Biochem. 1969, 28, 192-205.
26. Tennilä, T.; Azhayeva, E.; Vepsälänen, J.; Laatikainen, R.; Azhayev, A.; Mikhailopulo, I.A. Oligonucleotides containing 9-(2-deoxy-2-fluro-β-D-arabinofuranosyl)-adenine and -guanine: synthesis, hybridization and antisense properties. Nucleosides, Nucleotides & Nucl. Acids 2000, 19, 1861-1884.
27. Vorbrüggen, H.; Ruh-Pohlenz, C. Synthesis of nucleosides. Org. Reactions 2000, 55, 1-630.
28. Kalinichenko, E.N.; Podkopaeva, T.L.; Poopeiko, N.E.; Kelve, M.; Saarma, M.; Mikhailopulo, I.A.; Van Den Boogaart, J.E.; Altona, C. Role of the stereo-chemistry of 3′-fluoro-3′-deoxy analogues of 2-5A in binding to and activation of mouse RNase L. Rec. Trav. Chim. Pays-Bas 1995, 114, 43-50.
29. Maruyama, T.; Takamatsu, S.; Kozai, S.; Satoh, Y.; Izawa, K. Synthesis of 9-(2-deoxy-2-fluro-β-D-arabinofuranosyl)adenine bearing a selectively removable protecting group. Chem. Pharm. Bull. 1999, 47, 966-970.
30. Mikhailopulo, I.A.; Sivets, G.G.; Poopeiko, N.E.; Khripach, N.B. Oxidationreduction sequence for the synthesis of peracylated fluorodeoxy pentofuranosides. Carbohyd. Res. 1995, 278, 71-89.
31. 7-isomer. Bioorg. Med. Chem Lett. 1995, 5, 2999-3002.
32. Mikhailopulo, I.A.; Poopeiko, N.E.; Sivets, G.G.; Pricota, T.I.; Kvasyuk, E.I.; Balzarini, J.; De Clercq, E. Synthesis and antiviral and cytostatic properties of 3′-deoxy-3′-fluoro- and 2′-azido-3′-fluoro-2′,3′-dideoxy-D-ribofuranosides of natural heterocyclic bases. J. Med. Chem. 1991, 34, 2195-2202.
33. Van Wijk, J., Haasnot, C.A.G.; de Leeuw, F.A.A.M.; Huckriede, B.D.; Westra Hoekzema, A.J.A.; Altona, C. PSEUROT 6.3, Leiden Institute of Chemistry, Leiden University, The Netherlands, 1999.
34. Seela, F.; Debelak, H.; Reuter, H.; Kastner, G.; Mikhailopulo, I.A. Different conformation of 1-deazaadenosine and its 2′-deoxyribonucleoside in crystals and in solution. Tetrahedron 1999, 55, 1295-1308.
35. Thibaudeau, C.; Chattopadhyaya, J. Stereoelectronic Effects in Nucleosides and Nucleotides and their Structural Implications; Uppsala University Press: Sweden, 1999.
36. Thibaudeau, C.; Plavec, J.; Chattopadhyaya, J. A new generalized Karplus-type equation relating vicinal proton-fluorine coupling constants to H-C-C-F torsion angles. J. Org. Chem. 1998, 63, 4967-4984.
37. Van Den Boogaart, J.E.; Kalinichenko, E.N.; Podkopaeva, T.L.; Mikhailopulo, I.A.; Altona, C. Conformational analysis of 3′-fluorinated A(2′-5′)A(2′-5′)A fragments. Relation between conformation and biological activity. Eur. J. Biochem. 1994, 221, 759-768.
38. 13C Nuclear magnetic resonance spectroscopy of selected adenine nucleosides: structural correlation and conformation about the glycosidic bond. Org. Magn. Res. 1979, 12, 247-253.
39. Davies, D.B. Conformations of nucleosides and nucleotides. Progr. Nucl. Magn. Res. Spectr. 1978, 12, 135-225.
40. Johansson, K.; Ramaswamy, S.; Ljungcrantz, C.; Knecht, W.; Piškur, J.; Munch-Petersen, B.; Eriksson, S.; Eklund, H. Structural basis for substrate specificities of cellular deoxyribonucleoside kinases. Nature Struct. Biol. 2001, 8, 616-620.
41. Eriksson, S.; Kierdaszuk, B.; Munch-Petersen, B.; Oberg, B.; Johansson, N.G. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem. Biophys. Res. Commun. 1991, 176, 586-592.
42. Shugar, D. Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases. Pharmacol. Ther. 1999, 82, 315-335.
43. Sahyoun, N.; Schmitges, C.J.; Siegel, M.I.; Cuatrecasas, P. Inhibition of fat cell membrane adenylate cyclase by 2′-deoxyadenosine-3′-monophosphate. Life Sci. 1976, 19, 1971-1979.
44. Desaubry, L.; Shoshani, I.; Johnson, R.A. Inhibition of adenylyl cyclase by a family of newly synthesized adenine nucleoside 3′-polyphosphates. J. Biol. Chem. 1996, 271, 14,028-14,034.
45. Bushfield, M.; Shoshani, I.; Johnson, R.A. Tissue levels, source, and regulation of 3′-AMP: an intracellular inhibitor of adenylyl cyclases. Mol. Pharmacol. 1990, 38, 848-853.
46. Player, M.R.; Torrence, P.F. The 2-5A System: Modulation of Viral and Cellular Processes Through Acceleration of RNA Degradation. Pharmacol. Ther. 1998, 78, 55-113.
47. Park, I.; Ives, D.H. Properties of a highly purified mitochondrial deoxyguanosine kinase. Arch. Biochem. Biophys. 1988, 266, 51-60.
48. Zhu, C.; Johansson, M.; Permert, J.; Karlsson, A. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase. Biochem. Pharmacol. 1998, 56, 1035-1040.
49. In our earlier report [16] this value was incorrectly given as 15 μM, due to an error in the Hill equation employed.
50. This value was previously reported incorrectly as 2.5 μM [16], due to an error in the Hill equation employed.
51. Knecht, W.; Munch-Petersen, B.; Piškur, J. Identification of residues involved in the specificity and regulation of the highly efficient multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster. J. Mol. Biol. 2000, 301, 827-837.
52. Herrström Sjöberg, A.; Wang, L.; Eriksson, S. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. Mol. Pharmacol. 1998, 53, 270-273.
53. Spasokoukotskaja, T.; Csapo, Z.; Sasvari-Szekely, M.; Virga, S.; Talianidis, I.; Eriksson, S.; Staub, M. Effect of phosphorylation of deoxycytidine kinase activity. Adv. Experimental Med. Biol. 2000, 486, 281-285.
54. Wang, L.M.; Kucera, G.L. Deoxycytidine kinase is phosphorylated in vitro by protein kinase C alpha. Biochim. Biophys. Acta 1994, 1224, 161-167.
55. Csapo, Z.; Sasvari-Szkely, M.; Spasokoukotskaja, T.; Talianidis, I.; Eriksson, S.; Staub, M. Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes. Biochem. Pharmacol. 2001, 61, 191-197.
56. He, Q.; Skog, S.; Wu, C.; Johansson, A.; Tribukait, B. Existence of phosphorylated and dephosphorylated forms of cytosolic thymidine kinase (TK1). Biochim. Biophys. Acta 1996, 1289, 25-30.
57. Munch-Petersen, B.; Cloos, L.; Tyrsted, G.; Eriksson, S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 1991, 266, 9032-9038.
58. Herrström Sjöberg, A.; Wang, L.; Eriksson, S. Antiviral guanosine analogs as substrates for deoxyguanosine kinase: implications for chemotherapy. Antimicrob. Agents Chemother. 2001, 45, 739-742.